Talk to Sam
+1 718 473 0872
Download Unlimited Documents from Trusted Public Sources
Topics under TherapyPharmaceutical Related markets: Hospital, HIV AIDS, Infectious Disease, Hepatitis, Cardiovascular Disease, Anti-Infective, Opioid, Hormone, Antiviral, HIV Antiviral, Analgesic, Insulin, Monoclonal Antibody, Chemotherapy, Hepatitis Treatment, Targeted Therapy, Antidiabetics
Purchase Reports From Reputable Market Research Publishers
(From $ 175 - $ 8355)
Description As new targeted asthma therapies emerge, is time running out for Xolair? Xolair’s unique position in the targeted asthma treatment market is under threat. Teva’s Cinqair and GSK’s Nucala ...